←
Smart Science1,718 posts
Smart Science avatar

Smart Science

@SmartScience

🔬 Smart science facts • Space 🚀 Physics ⚛️ Biology 🧬 Tech 🤖 • Learn something new every day

◷ Joined March 2026▧ 1,649 Photos and videos
Smart Science avatar
Smart Science@SmartScience·4h

Representative Marie Gluesenkamp Perez introduced the LIGHT Safety Act, a bill that would establish the first federal limits on the brightness of vehicle headlights in the. U.S. The LIGHT Safety Act, short for the Limiting Intense Glare for Highway and Two-lane Safety Act (H.R. 7772) would direct the Department of Transportation, through the National Highway Traffic Safety Administration, to rewrite the federal headlight standard within a year of becoming law. The new rule would have to set a maximum brightness for low beams, measured in lumens or another unit regulators choose. Glare has become one of drivers' most common complaints as bright LED headlights have spread to more than 80% of new cars. In a AAA survey released in March, six in 10 drivers said headlight glare is a problem after dark, and 73% of them said it has gotten worse over the past decade. "This is something that draws ire from rural Americans, from older Americans, from law enforcement," Gluesenkamp Perez said when she first pushed for a cap. That said, this is still only a bill. Also, it doesn't set a number itself, so the actual limit would be up to regulators. Even so, it gives drivers who are tired of being blinded a concrete proposal to rally behind. source: LIGHT Safety Act, H.R. 7772, 119th Cong. (2026). AAA. (2026). New AAA survey: Six in ten drivers struggle with headlight glare.

Post attachment
Smart Science avatar
Smart Science@SmartScience·13h

Every extra 200 grams of fruit and vegetables a day is linked to a 16% lower risk of depression. Researchers at Tehran University of Medical Sciences, led by Nazanin Zamanian and Sepide Talebi, pooled 13 long-term studies that followed 385,449 adults in the United States, Australia, France, Spain, China and Japan for anywhere from about two years to nearly two decades. Over that time, 26,592 of them developed depression. People who ate the most fruit had a 16% lower risk than those who ate the least, and the biggest vegetable eaters had a 12% lower risk. In the four studies that measured fruit and vegetables together, the top eaters had a 37% lower risk, and every extra 200 grams a day was tied to a 16% drop. Depression rates have climbed in recent years, so a link to something as everyday as what lands on the dinner plate is worth paying attention to. Fruit and vegetables are full of antioxidants and fiber, which feed gut bacteria and help calm inflammation, and researchers think both may influence mood through the gut-brain connection, although this review didn't test those pathways directly. Still, these are observational studies, so they show a link rather than proof that produce prevents depression, and factors like income or access to healthcare could explain part of it. The authors say trials that randomly assign people to different diets are the next step to show whether loading up on produce truly protects mental health. source: Zamanian, N., Torabinasab, K., Moradi Baniasadi, M., Kavyani, Z., Amiri, S. M., Sadeghi Majd, S., Mohajerani, A., & Talebi, S. (2026). Association between fruit and vegetable intake and risk of depression: A systematic review and meta-analysis of prospective cohort studies. Journal of Affective Disorders.

Post attachment
Smart Science avatar
Smart Science@SmartScience·18h

Four weekly injections of engineered bacteria just shrank aggressive breast tumors — and cut the number of cancer cells reaching other organs. The team at Jeonbuk National University in South Korea started with Salmonella Typhimurium, the bug behind a nasty bout of food poisoning, and deleted four of its genes. The crippled strain, JOL3136, now depends on an amino acid called tryptophan that it finds inside tumors but not easily elsewhere, so it piles up in the cancer and largely leaves healthy tissue alone. Then they gave it two jobs: inside tumor cells it makes apoptin, a protein that pushes cancer cells into self-destruction while sparing healthy ones, and on its surface it displays a fragment of a tumor marker called CEA, a wanted poster that teaches the immune system what to attack. Mice with aggressive breast tumors got four weekly doses, and their tumors came out far smaller than in the control groups, with many fewer cancer cells reaching the lungs, liver and spleen. Bacteria have a strange talent for cancer: they thrive in the low-oxygen core of a tumor, where chemotherapy and immune cells struggle to reach, and the problem has always been making them safe enough to inject. This work suggests one engineered strain can both kill tumor cells directly and wake an immune response that follows the cancer where it tries to spread. Still, this is a mouse study, and the researchers note they have not yet teased apart how much of the benefit comes from the bacterium, the apoptin or the tumor marker. Also, a living therapy built from a dangerous species needs tighter safety switches before it goes near a person. Their next steps are exactly that: stronger biological safeguards and tests in models that behave more like human tumors. source: Jeonbuk National University. (2026). Team develops dual-action bacterial cancer therapy [Press release]. Lee, J. H., et al. (2026). Therapeutic Salmonella expressing apoptin and CEA elicits combined pro-apoptotic and immune-mediated anticancer effects. Biomedicine & Pharmacotherapy, 202, 119840.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 17

🚨 Kids with smartphones before 12 face higher risks of depression, poor sleep, and obesity A new study summarized by CBS News suggests that owning a smartphone before age 12 is linked to higher risks of depression, poor sleep, and obesity among young adolescents. Drawing on data from more than 10,000 U.S. participants in the National Institutes of Health–funded Adolescent Brain Cognitive Development (ABCD) Study, researchers from Children’s Hospital of Philadelphia, the University of California, Berkeley, and Columbia University found that 63.6% of adolescents owned a smartphone, with a median acquisition age of 11. The analysis indicated that the younger children were when they received their first smartphone, the greater their likelihood of reporting insufficient sleep and obesity, and that children without smartphones by age 12 had better mental health one year later, even after accounting for access to other devices like tablets. Lead author Ran Barzilay emphasized that the study focused on the simple fact of smartphone ownership rather than specific types of use, raising questions about how merely having a device may shape health outcomes in early adolescence. With smartphone ownership now nearly universal among teens and increasingly common among children as young as 5, the researchers plan to explore which patterns of use are most harmful or beneficial and to identify strategies—such as monitoring content and protecting sleep—to help families mitigate risks while preserving potential advantages. References: Czachor, E. M. (2025, December 1). Children who have smartphones by age 12 are at increased risk of health problems, new study finds. CBS News. Barzilay, R., et al. (2025). Smartphone ownership, age of smartphone acquisition, and youth health outcomes. Pediatrics.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 17

Two scientists just won the 2026 Brain Prize for uncovering mechanics of touch. Every caress, pinch and burn you feel starts with specialized nerve cells in your skin, and the two scientists who mapped them won the world's largest brain research prize. The 2026 Brain Prize, awarded by Denmark's Lundbeck Foundation, went to David Ginty of Harvard Medical School and Patrik Ernfors of Karolinska Institutet in Sweden. Over decades, the two classified the distinct types of sensory nerve cells in the body and linked each one to its own endings in the skin and its own route through the spinal cord to the brain. That work explains how stroking, vibration, pressure, heat and pain get turned into separate signals the brain can read. Ernfors's lab also reported in 2019 that some Schwann cells, support cells that wrap around nerves, form a mesh in the skin that helps sense painful touch, at least in mice. This matters because chronic pain is one of the most common reasons people suffer and see a doctor, yet most painkillers act bluntly on the whole nervous system. The prize committee said the winners' work gives a blueprint for finding exactly where things go wrong in chronic pain and in conditions that make people over- or under-sensitive to touch. Knowing which cells carry which sensations gives drug developers far more precise targets than the painkillers we rely on today. source: Lundbeck Foundation. (2026). The world's largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain [Press release].

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 17

Scientists designed a protein that doesn’t exist in nature — and used it to turn off a whole family of food allergens. Many allergy-causing proteins in peaches, apples, hazelnuts, and almonds belong to one family, called lipid transfer proteins, and they look alike enough that a person allergic to one often reacts to the rest. So the team at the Technical University of Denmark averaged them into a single synthetic allergen carrying the family's shared features, and wrote the recipe into an mRNA vaccine of the kind made familiar by COVID shots, so the body builds the lookalike itself and learns to handle it. Healthy mice produced large amounts of protective IgG antibodies after one dose, and after three doses those antibodies recognized a whole range of related allergens. In allergic mice, antibody levels rose sharply with almost no side effects, and in the lab those antibodies damped down reactions in blood from allergic patients. For most people with food allergies, the only real treatment today is years of swallowing slowly rising doses of the exact food that makes them ill, one allergen at a time, and it does nothing about the next related food that trips the same switch. A shot covering a whole family would be a different proposition, and the team is already designing a second one for the allergens behind apple, carrot and hazelnut reactions. To be clear, this is a proof of concept in mice, and at the doses tested the vaccine did not fully protect allergic animals against anaphylaxis, the severe whole-body reaction that makes food allergy dangerous. Also, nothing has been tried in a person yet. The researchers' next step is to pin down dose and schedule in larger mouse studies and gather what regulators need before a first human trial. source: Technical University of Denmark. (2026). Eating without fear: A single vaccine shows promise against multiple food allergies [Press release]. Moiniche, M., et al. (2026). An mRNA-delivered consensus allergen induces a neutralizing IgG response against food and pollen allergens. Nature Communications.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 17

Tiny radioactive seeds implanted straight into the brain cleared away visible glioblastoma tumors in five patients — and every patient treated in the trial is still alive. The treatment, called Alpha DaRT, places seeds loaded with radium-224 directly inside the tumor during surgery. As the radium decays it throws off alpha particles, a short-range, extremely destructive radiation that shreds the DNA of cells within a few millimeters and then fades, hitting the tumor hard without irradiating the rest of the brain. In the REGAIN trial at the Ohio State University Comprehensive Cancer Center, eight people with recurrent glioblastoma have been treated and six have had response scans. All six responded: five had a complete response, meaning no measurable tumor left on imaging, and the sixth's tumor shrank by 58%. As of November 11, all eight were still alive. Glioblastoma is the brain cancer that kills most of the people it touches. Median survival is around eight months, only about 7% of patients are alive five years later, and when the tumor returns after surgery and radiation there is very little left to offer. A single procedure that wipes a recurrent tumor off the scans would be a real shift in what doctors can do. That said, this is the company's own interim announcement covering eight patients, presented as a conference poster rather than a peer-reviewed paper, and three of the six responses still need confirming on later scans. Also, four of the six developed radiation necrosis, dead and inflamed tissue at the treatment site, and in two cases scans cannot yet tell necrosis from the tumor growing back. Alpha Tau is enrolling toward 20 patients, which it says may be enough to support a submission to regulators. source: Alpha Tau Medical. (2026). New positive interim results from its U.S. Alpha DaRT recurrent glioblastoma trial [Press release]. REGAIN interim data presented at the 31st Annual Meeting of the Society for Neuro-Oncology.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 16

Rising parent refusals of vitamin K shots in the U.S. have triggered a sharp spike in preventable infant bleeding emergencies and brain hemorrhages. A dangerous health trend is surfacing across American maternity wards as a growing number of parents opt out of routine newborn vitamin K injections. Infants are naturally born with dangerously low levels of vitamin K because the essential nutrient does not easily pass through the placenta, nor is it transferred in sufficient amounts through breast milk. Without this critical vitamin, a baby's body cannot produce the clotting factors needed to halt internal and external bleeding, leaving newborns defenseless against severe hemorrhaging. Medical experts warn that skipping this standard post-birth injection significantly increases the risk of Vitamin K Deficiency Bleeding, a condition that can trigger sudden intracranial hemorrhages, permanent neurological damage, or fatal complications within an infant's first six months of life. Although pediatricians have recommended a single dose at birth since 1961, rising medical distrust and misinformation have driven up refusal rates, leading to an alarming surge in preventable infant bleeding cases nationwide. source: Wolf, E. R., Woolf, S. H., French, E., & Shokouhi Niaki, D. (2026). Trends in Vitamin K Deficiency and Bleeding Among US Infants. JAMA Pediatrics.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 16

Research shows casual gaming can reduce anxiety, stress, and depression. Scientists in New Zealand reviewed 13 studies of nine casual video games, the simple, low-pressure kind you can play in short bursts, like puzzles and match-three games. Six of the studies looked at anxiety, two at depression and four at stress or low mood, and the authors concluded the games show real promise for easing all four. A later and much larger review of 145 trials in young people, published in Clinical Psychology Review, found that casual games used as a distraction worked as well as or better than standard care for managing anxiety in medical settings, such as before surgery. That matters because casual games are cheap, carry no stigma and are already on most people's phones, so they could reach people who would never sign up for therapy. They seem to work partly by pulling attention away from worry and giving the mind a small, satisfying task to focus on. That said, many of the studies were small and used different games and measures. But a free, low-pressure tool people already carry in their pockets is an appealing lead for researchers looking for new ways to support mental health. source: Pine, R., Fleming, T., McCallum, S., & Sutcliffe, K. (2020). The effects of casual videogames on anxiety, depression, stress, and low mood: A systematic review. Games for Health Journal, 9(4), 255–264.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 16

A study from the University of Oulu found that 40 minutes on a vibrating mattress, combined with blood-pressure-lowering medication, increased Alzheimer's-linked proteins in the blood of 29 healthy adults.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 16

Clarice Phelps helped put element 117 on the periodic table. She was the first Black woman to help discover a new element. Clarice Phelps helped put element 117 on the periodic table, becoming the first Black woman known to help discover a new element. Phelps, a Tennessee State University chemistry graduate, spent four years in the U.S. Navy's nuclear power program before joining Oak Ridge National Laboratory in 2009. There she worked on purifying berkelium, a rare radioactive element made in only a handful of reactors on Earth. That berkelium was shipped abroad and used as the target material in experiments that confirmed element 117, now named tennessine. In 2019, the International Union of Pure and Applied Chemistry recognized her as the first African American woman involved in the discovery of an element. Tennessine is the second-heaviest element ever confirmed, and it was named after Tennessee to honor the lab and universities whose work made it possible. Phelps has called her path to the periodic table "a 20-year journey," and she now works on industrial isotopes at Oak Ridge while speaking to students about careers in science. Her story is a reminder that big discoveries are built by teams, and that the people doing the painstaking lab work deserve credit too. sources: International Union of Pure and Applied Chemistry. (2019, June 2). Clarice Phelps. IUPAC Periodic Table of Younger Chemists; Tennessee State University. (2024, February 6). TSU grad first Black female to help discover element for periodic table. TSU Newsroom.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 16

According to Study. com, biologically the female body has the capacity to undergo pregnancy and childbirth many times over a lifetime, with theoretical estimates suggesting up to around 30 births under ideal conditions. This estimate is based on human reproductive biology, including the age of fertility onset, recovery time between pregnancies, and the natural end of fertility at menopause, as explained in Study. com’s overview of human reproduction. Historical records from eras without modern contraception show rare cases of women giving birth to exceptionally large numbers of children, supporting this biological possibility.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 15

A new THC treatment locks breast cancer cells in a less aggressive state, significantly preventing them from spreading. And the treatment only takes four days to work. Traditionally, cancer treatments aim to aggressively kill cancer cells, but this evolutionary pressure can cause remaining cells to revert to a primitive, stem-cell-like state, making them highly invasive and resistant to therapy. To address this, a team of researchers investigated a different approach: forcing cancer cells to "mature" and lock into a less harmful state. Published in Communications Biology, their study demonstrated that treating lab-grown, 3D human breast cancer models with an ultra-low dose of tetrahydrocannabinol (THC)—the primary active compound in cannabis—for just four days durably reprogrammed the cells, preventing them from reverting to a highly aggressive, metastatic state. The treatment specifically targeted the CB2 cannabinoid receptor, triggering cellular changes that dramatically reduced the tumor models' invasiveness, self-renewal capabilities, and ability to seed new tumors. When these THC-exposed cancer cells were later transplanted into animal models, they formed tumors far more slowly and resulted in significantly fewer lung metastases. This "differentiation therapy" not only halted the spread of the cancer but also rendered the remaining cells more sensitive to standard endocrine treatments like tamoxifen. While clinical trials are still needed, this breakthrough offers a promising, non-toxic strategy to constrain the adaptive flexibility of breast cancer cells. source: Martínez-Illescas, N. G., Quezada-Gutiérrez, C., Pérez-García, G., & Salazar-Roa, M. (2026). Transient CB2R modulation durably restricts breast cancer plasticity by stabilizing a luminal like cell identity. Communications Biology.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 15

That black on your onions isn’t dirt — it’s a fungus called Aspergillus niger that thrives in humid storage conditions. Many home cooks mistake the black, powdery residue found on onion skins for simple garden dirt. In reality, this substance is Aspergillus niger, a common fungus that develops after harvest when onions are stored in high-humidity environments with poor airflow. While it primarily affects the dry, papery outer layers, identifying this mold correctly is the first step in ensuring your kitchen prep remains safe and your produce lasts longer. The safety of the onion depends on how deep the fungus has reached. If the black spots are confined to the outer skin, you can simply peel away the affected layers and use the firm, odor-free bulb inside. However, if the onion has become soft, slimy, or develops a noticeable smell, it must be discarded immediately. It is a common misconception that heat solves the problem; while cooking may kill the fungus itself, it does not reliably eliminate the harmful mycotoxins that can linger within the vegetable. Source: University of California Agriculture and Natural Resources. (2023). Onion: Black Mold (Aspergillus niger). Statewide Integrated Pest Management Program.

Post attachment
AstroScroll avatar
⟳ Smart Science retweeted
AstroScroll@astroscroll·Nov 15

NASA has captured a stunning picture of NGC 2264 an open cluster of stars that looks like a giant Christmas tree.

Post attachment
Smart Science avatar
Smart Science@SmartScience·Nov 15

Patients got their vision back after surgeons put lab-grown eye cells under their retinas. Surgeons at Moorfields Eye Hospital, working with University College London, grew a layer of retinal pigment epithelium, the cells that nourish and support the eye's light-sensing cells, from human embryonic stem cells on a thin synthetic patch. In a one-to-two-hour operation, they slipped the patch under the retina of two patients, a woman in her 60s and a man in his 80s, who had suddenly lost much of their sight to severe wet age-related macular degeneration (AMD). Twelve months later, both had gone from being unable to read even with glasses to reading 60 to 80 words per minute with ordinary reading glasses. The results were published in Nature Biotechnology. AMD is the leading cause of vision loss in older adults, and it destroys the sharp central vision people use to read, drive and recognize faces. Today's injections for wet AMD can slow the damage, but they can't replace cells that have already died, which is what this patch was designed to do. The work came out of the London Project to Cure Blindness, which aimed to turn it into an affordable "off-the-shelf" treatment. It showed for the first time that lab-grown tissue can bring back a skill as precious as reading, and it sets the template for the stem cell eye trials that follow. source: da Cruz, L., Fynes, K., Georgiadis, O., Kerby, J., Luo, Y. H., Ahmado, A., ... & Coffey, P. J. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nature Biotechnology, 36(4), 328-337.

Post attachment